Regulatory Affairs China - Marketing Authorisation in China
- The CFDA and further authorities, agencies + ministries
- Documents for the application
- Maintenance of the licence
- IP protection
India and China are lucrative markets for European pharmaceutical products. With more than 1 billion inhabitants each, they are the most populous countries in the world. But what are the requirements for a successful marketing authorisation (generics and NCEs)? In this seminar you will learn about
- clinical trials in these countries
- the drug registration procedures
- dossier requirements
- post-approval regulatory processes and much more.
After having attended this seminar the participants will be familiar with the critical points in the marketing authorisation procedures and know how to maintain a granted marketing authorisation.
Termin
| Datum: | 19.03.2015 |
| Ort: | NH Frankfurt City Vilbeler Straße 2 -60313 Frankfurt |
| Preis: | 950,00 EUR zzgl. MwSt. |
Zielgruppe
This seminar will be of benefit to anyone working in the pharmaceutical industry interested in marketing pharmaceuticals in India and China.
Especially those working in regulatory affairs and business development will profit from the seminar.
Kontaktinformationen
Weitere Pharma-Seminare, die Sie interessieren könnten:
| 25.04.2024 | Laborplanung mit Lean Lab Design - Webinar |
| 20.06.2024 | Laborplanung mit Lean Lab Design - Webinar |
| 11.07.2024 | Lean Lab – Erfolgreiche Optimierungen im Labor |
| 10.10.2024 | Laborplanung mit Lean Lab Design - Webinar |
| 12.06.2024 | Lean Management im Labor (2 Tage) |
